AstraZeneca COVID vaccine will be available for poor countries – media

The vaccine will cost about $ 4, and it will also be easier to transport and store, since it does not require very low temperatures.

The coronavirus vaccine, developed by scientists at Oxford University and AstraZeneca, will be more affordable in poor countries than other vaccines. It was reported by The Guardian on Monday, November 23.

In particular, AstraZeneca vaccine can be transported and stored for up to six months under standard refrigeration conditions, at temperatures of +2 to +7. It will also cost around $ 4, which is several times cheaper than the Pfizer / BioNTech and Moderna vaccines.

Furthermore, the efficacy of the vaccine can still be as high as 90% at a lower concentration in the first dose. Although the results at first glance appear different from those of Pfizer and Moderna, the scientists insist on the disparity, as Oxford and AstraZeneca vaccinated people in the mild to severe stages of COVID-19.

Lastly, the AstraZeneca vaccine has been shown to be very effective in both the elderly and young adults.

“We have a vaccine for the world, its effectiveness is high, it prevents serious diseases and hospitalizations. These are amazing results. Because this vaccine can be stored at refrigerator temperature, it can be distributed around the world using a conventional immunization system. “. the goal is to have a vaccine that is available everywhere, “said Andrew Pollard, director of the Oxford Vaccine Group.

Let’s remember that the G20 will help to distribute the vaccine equitably. G20 leaders worry that the pandemic could further exacerbate the divisions between rich and poor.

It was also reported that the G20 countries are asking for $ 5 billion for a COVID vaccine for poor countries. Adequate funding is needed for a global strategy to overcome the pandemic, GAVI said.

News of Correspondent.net on Telegram. Subscribe to our channel https://t.me/korrespondentnet